The stock of Aceto Corporation (NASDAQ:ACET) is a huge mover today! About 255,401 shares traded hands or 41.71% up from the average. Aceto Corporation (NASDAQ:ACET) has declined 31.70% since April 4, 2016 and is downtrending. It has underperformed by 32.79% the S&P500.
The move comes after 6 months positive chart setup for the $501.82 million company. It was reported on Nov, 4 by Barchart.com. We have $26.22 PT which if reached, will make NASDAQ:ACET worth $286.04 million more.
According to Zacks Investment Research, “Aceto Corporation markets, sells and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products and specialty chemicals. The company’s operating segment consists of Human Health, Pharmaceutical Ingredients and Performance Chemicals. Human Health segment supplies raw materials used in the production of nutritional and packaged dietary supplements. It markets and distributes its generic prescription and over the counter pharmaceutical products. Pharmaceutical Ingredients segment offers active pharmaceutical ingredients and pharmaceutical intermediates. Performance Chemicals segment provides specialty chemicals. It serves chemical, agricultural, human health and pharmaceutical industries. The company operates primarily in United States, Europe, and Asia. Aceto Corporation and is headquartered in Port Washington, New York.”
Insitutional Activity: The institutional sentiment decreased to 0.86 in 2016 Q2. Its down 0.62, from 1.48 in 2016Q1. The ratio is negative, as 16 funds sold all Aceto Corporation shares owned while 49 reduced positions. 11 funds bought stakes while 45 increased positions. They now own 23.91 million shares or 7.56% less from 25.86 million shares in 2016Q1.
Fisher Asset Mgmt Limited Liability Corporation accumulated 0.01% or 167,853 shares. Rhumbline Advisers last reported 0% of its portfolio in the stock. Redwood Invs Limited accumulated 0.23% or 115,560 shares. Schwab Charles has 108,532 shares for 0% of their US portfolio. Comerica National Bank accumulated 0.01% or 29,541 shares. Bryn Mawr Trust holds 0.28% or 203,181 shares in its portfolio. Ubs Asset Americas has 13,649 shares for 0% of their US portfolio. Moreover, Denver Invest Advsrs Ltd Limited Liability Company has 0.44% invested in Aceto Corporation (NASDAQ:ACET) for 446,128 shares. Texas Permanent School Fund has invested 0.01% of its portfolio in Aceto Corporation (NASDAQ:ACET). Louisiana State Employees Retirement Systems has invested 0.02% of its portfolio in Aceto Corporation (NASDAQ:ACET). Moreover, Motley Fool Wealth Management Limited Liability has 0.32% invested in Aceto Corporation (NASDAQ:ACET) for 133,520 shares. Sei Invests Com reported 95 shares or 0% of all its holdings. Zebra Cap Mngmt Limited Liability Corp has invested 0.22% of its portfolio in Aceto Corporation (NASDAQ:ACET). State Of Tennessee Treasury Department holds 0% of its portfolio in Aceto Corporation (NASDAQ:ACET) for 23,248 shares. Goldman Sachs Grp has 35,524 shares for 0% of their US portfolio.
Insider Transactions: Since May 26, 2016, the stock had 0 insider buys, and 30 sales for $3.10 million net activity. Another trade for 3,275 shares valued at $76,426 was made by DEBENEDITTIS FRANK on Thursday, July 7. Alaimo Charles John sold $50,955 worth of stock or 2,567 shares. $155,120 worth of Aceto Corporation (NASDAQ:ACET) was sold by ROTH DOUGLAS A. $26,222 worth of shares were sold by Kippley Terry on Thursday, September 1. The insider EILENDER ALBERT L sold 7,690 shares worth $173,219. 4,200 shares were sold by BRITTON WILLIAM N, worth $97,100. 10,945 shares were sold by GUCCIONE SALVATORE J SR, worth $254,420 on Wednesday, July 6.
More notable recent Aceto Corporation (NASDAQ:ACET) news were published by: Streetinsider.com which released: “ACETO Corp (ACET) Announces $412M Acquisition of Certain Assets from Citron …” on November 03, 2016, also Fool.com with their article: “Why Shares of Aceto Corporation Plunged 23% Today” published on August 26, 2016, Globenewswire.com published: “ACETO Corporation Schedules Fourth Quarter & Fiscal 2016 Financial Results …” on August 12, 2016. More interesting news about Aceto Corporation (NASDAQ:ACET) were released by: Globenewswire.com and their article: “ACETO Corporation Announces $125 Million Convertible Notes Offering” published on November 09, 2015 as well as Globenewswire.com‘s news article titled: “ACETO Corporation Schedules First Quarter Fiscal 2017 Financial Results News …” with publication date: October 21, 2016.
ACET Company Profile
Aceto Corporation (Aceto), incorporated on June 13, 1947, is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company’s business is organized along product lines into three divisions: Human Health, Pharmaceutical Ingredients and Performance Chemicals. As of June 30, 2016, the Company distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical industries. The Firm has presence in China, Germany, France, The Netherlands, Singapore, India, Hong Kong, Philippines, the United Kingdom and the United States.